A study comparing two ultrasound-guided approaches (anterior and posterior) for hydrodilatation with suprascapular nerve block to reduce pain and improve shoulder movement in patients with frozen shoulder.

Comparative evaluation of USG guided anterior versus posterior approach hydrodilatation with adjuvant suprascapular nerve block in patients with frozen shoulder:A randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106525

Enrollment

Registered

2026-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: USG guided anterior approach hydrodilatation with suprascapular nerve block: Ultrasound guided suprascapular nerve block followed by anterior approach glenohumeral joint hydrodilatation

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis of primary adhesive capsulitis / frozen shoulder: shoulder pain and restriction of both active and passive ROM (especially external rotation) for more than or equal to 4 weeks and less than or equal to 12 months. 2.Pain interfering with ADLs and baseline SPADI more than 30. 3.Patients who have not improved with conservative treatment(analgesics and physiotherapy)for 6 weeks under orthopaedic department care 4.Able to give written informed consent and comply with follow-up and physiotherapy

Exclusion criteria

Exclusion criteria: 1.Prior shoulder surgery on affected side. 2.Full-thickness rotator cuff tear (on prior imaging) or by clinical examination or history wise or severe glenohumeral osteoarthritis. 3.Recent (less than 3 months) intra-articular steroid injection or hydrodilatation. 4.Neurological disorder affecting shoulder function. 5.Coagulopathy / on anticoagulants not eligible for injection or SSNB. 6.Active local or systemic infection, uncontrolled diabetes with blood sugar values more than 250mg/dL,HbA1c more than 8 percentage,pregnancy. 7.Allergy to study medications (local anesthetic, steroid).

Design outcomes

Primary

Measure	Time frame
To elicit the change in Shoulder Pain And Disability Index (SPADI) score from baselineTimepoint: Baseline and 12 weeks post intervention	—

Secondary

Measure	Time frame
1.To compare change in pain (VAS) at rest and on movement at 1, 4 and 12 weeks. 2.To compare improvements in active and passive ROM (flexion, abduction, external rotation, internal rotation) at 1, 4 and 12 weeks. 3.To determine the time to clinically meaningful improvement more than or equal to 13-point SPADI change). 4.To assess patient global satisfaction and analgesic consumption. 5.To find out adverse events and complications (infection, steroid reactions, nerve injury).Timepoint: 1,4 and 12 weeks	—

Measure

Time frame

1.To compare change in pain (VAS) at rest and on movement at 1, 4 and 12 weeks. 2.To compare improvements in active and passive ROM (flexion, abduction, external rotation, internal rotation) at 1, 4 and 12 weeks. 3.To determine the time to clinically meaningful improvement more than or equal to 13-point SPADI change). 4.To assess patient global satisfaction and analgesic consumption. 5.To find out adverse events and complications (infection, steroid reactions, nerve injury).Timepoint: 1,4 and 12 weeks

—

Countries

India

Contacts

Public ContactDr Anuja S Kurukkal

Institute of Anaesthesiology, Madurai Medical College

rani4kalyan@yahoo.co.in9842111311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026